Maia Wealth’s Pyxis Oncology PYXS Stock Holding History

Maia Wealth’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-118,900	Closed	-$12	–	333
2025 Q1	$12	Hold	118,900	–	–	﹤0.01%	292
2024 Q4	$951	Buy	+118,900	New	+$343K	﹤0.01%	324

Other funds holding PYXS

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GGI

GordonMD Global Investments Beverely Hills, California $144M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maia Wealth's PYXS Position: Q1 2026 in Review

Maia Wealth reduced its Pyxis Oncology (PYXS) stake by 3.1% in Q1 2026, selling an estimated $1.03K and leaving 21,277 shares worth $31.1K. The position accounts for 0.01% of the portfolio, ranked #346.

Maia Wealth first reported a position in PYXS in Q4 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

Maia Wealth held 21,277 shares of Pyxis Oncology worth $31.1K as of Q1 2026.
Maia Wealth sold 682 Pyxis Oncology shares in Q1 2026, an estimated $1.03K.
Pyxis Oncology made up 0.01% of Maia Wealth's portfolio in Q1 2026, its #346 holding.
Maia Wealth first reported a position in Pyxis Oncology in Q4 2025 and has held it in 2 quarters since.
78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Maia Wealth's 13F filing for Q1 2026, filed 8 May 2026.